Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function

🩺 Protocol Summary

This is a clinical trial designed to examine how improved sleep through morning bright light therapy is improving downstream key physiologic processes related to brain health, i.e., mitochondrial function, systemic inflammation, and glymphatic function. All proposed methodology is already approved in other IRB applications.

Primary Research Facility: Oregon Health and Science University (Portland, Oregon)

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Sleep?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged between 18 Years and 89 Years?

🔍 Protocol Specified Age Range: 18 Years to 89 Years

Able to attend required clinic visits at Oregon Health and Science University (Portland, Oregon)?

🔍 Logistical Requirement: Site at Oregon Health and Science University

📍 Primary Site Map

Site: Oregon Health and Science University — Portland, Oregon

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.